Fingerprint
Dive into the research topics of 'Regorafenib plus modified FOLFOX6 as first-line treatment of metastatic colorectal cancer: A phase II trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Regorafenib plus modified FOLFOX6 as first-line treatment of metastatic colorectal cancer: A phase II trial
Guillem Argilés, Mark P. Saunders, Fernando Rivera, Alberto Sobrero, Al Benson, Carmen Guillén Ponce, Stefano Cascinu, Eric Van Cutsem, Iain R. MacPherson, Dirk Strumberg, Claus Henning Köhne, John Zalcberg, Andrea Wagner, Vittorio Luigi Garosi, Julia Grunert, Josep Tabernero, Fortunato Ciardiello*
*Corresponding author for this work
Research output: Contribution to journal › Article › peer-review
50
Scopus
citations